Selection of bispecific antibody therapies or CAR-T cell therapy in relapsed lymphomas

已取消 10 由 1727 发布于 2024/5/27 12:39:20

DOI:10.1182/hematology.2023000438
作者：Ajay Major, M. Kamdar
文献类型：期刊论文
补充材料：只需要正文

American Society of Hematology (ASH)

Abstract： Patients with relapsed and refractory (R/R) aggressive B-cell non-Hodgkin lymphomas have historically poor survival outcomes, with chimeric antigen receptor T-cell (CAR-T) therapy now pres

应助信息

2024-05-27

Book学术机器人

2024/5/27 12:39:20 未找到该文献，机器人已退出，请等待人工下载

2024/5/27 12:39:20 Book学术AI机器人收到请求，开始寻找文献

2024/5/27 12:39:20 已向机器人发送请求

2024-05-27

1727 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Association for the Advancement of Science (AAAS)Kink bands promote exceptional fracture resistance in a NbTaTiHf refractory medium-entropy alloy